State Secures Over ₹84,000 Crore in Life Sciences Investments; Positions Itself as Global Hub
Telangana has solidified its standing as a significant global player in the life sciences arena, attracting more than ₹84,000 crore in investments over the past two years. This substantial financial backing fuels a burgeoning ecosystem that now hosts over 2,000 life sciences companies, contributing significantly to the state's economy and its global healthcare supply chain role. The sector's valuation now exceeds $80 billion, with Hyderabad emerging as a critical centre for innovation and manufacturing.
Hyderabad Ranked Among Top Global Clusters
Hyderabad is now recognized among the world's top seven life sciences clusters, a distinction no other Indian city shares. This elevated status is supported by the state's capacity to supply one-third of the global vaccine demand and its role as a manufacturing and R&D partner for major international firms. The region boasts one of the highest concentrations of USFDA-approved pharmaceutical facilities globally, with over 250 such sites.
Read More: Cerebras IPO Surges 89%, Raises $5.55 Billion on Debut
Investment Drivers and Future Policy
Global investment in Telangana's life sciences sector is propelled by a strategic shift of multinational pharmaceutical and biotech companies seeking alternatives to traditional hubs in the West and East Asia. Key growth areas include vaccines, consumer healthcare, advanced analytics, and laboratory infrastructure. The state is actively cultivating this growth through policies like the 'Next-Gen Life Sciences Policy 2026-30', designed to attract scaled investments and foster a mature, globally connected ecosystem.
The state government is also prioritizing the establishment of the Telangana School of Life Sciences, envisioned as a premier institution for advanced research, innovation, and talent development. This initiative aims to further cement Telangana's global leadership by cultivating specialized expertise and driving cutting-edge scientific advancements.
Expanding Global Footprint and Job Creation
Companies are expanding operations in Hyderabad, drawn by its robust data and AI talent pool, strong academic base, and cost advantages. Recent announcements include US-based Tredence Inc. establishing a dedicated healthcare and life sciences analytics hub and France-headquartered Opella Healthcare expanding its global capability centre. These expansions, alongside other multinational investments, are projected to create around 200,000 jobs across various life sciences sub-sectors, including pharmaceuticals, biotechnology, medical devices, and digital health.
Read More: Toddy Tappers Face Danger from Falls, Police, and Power Lines
Genome Valley as an Anchor
The Genome Valley, a sprawling 2,000-acre cluster on Hyderabad's outskirts, serves as the anchor for the state's life sciences ecosystem. It currently hosts over 200 biotech and pharmaceutical companies from various countries. The state also supports its R&D efforts with over 20 incubators and approximately 40 national research and academic institutions.
AI's Role in Sector Evolution
Artificial intelligence is increasingly recognized as a transformative force within the life sciences sector, particularly in drug development. Companies are focusing on fostering a digital mindset to leverage AI for enhanced research and operational efficiencies. This integration of AI is central to moving the sector's Global Capability Centres (GCCs) up the value chain towards more strategic, technology-led work.
Read More: Medpace Q1 2026: Higher Cancellations Affect Drug Trial Growth
